Aveir VR – Oversensing/Noise Reversion During Talking

Short answer: Yes—plausible and clinically observed. In leadless VVI devices such as the Aveir VR, non‑cardiac signals can couple to the sensing circuit. During speech, neck/diaphragmatic muscles and respiratory motion can generate high‑frequency myopotentials or cyclical baseline shifts. If these are interpreted as ventricular events (VS), the pacemaker may inhibit pacing or enter a noise response behavior, producing pauses, irregular timing, and fusion/pseudofusion that patients perceive as palpitations or discomfort.

Why this happens (mechanisms)

• Myopotential oversensing: High‑frequency EMG from laryngeal/diaphragmatic contraction is sensed as spurious ventricular activity, shortening V–V intervals and intermittently inhibiting a needed pace.
• Respiratory motion/vibration: Phonation and breathing alter thoracic mechanics; small vibrations or motion near the device can create non‑physiologic signals on the EGM.
• Algorithmic response: When rapid, non‑physiologic sensing is detected, devices may revert to a protective asynchronous/noise mode for short periods, changing timing regularity.

How to confirm (single‑visit provocation protocol)

• Tasks: quiet breathing → sustained vowels (low/high pitch; soft/loud) → humming → counting aloud → paced diaphragmatic breathing → brief Valsalva and cough.
• Capture: intracardiac EGM with marker channel (VS/VP), device diagnostics (noise/oversensing counters), synchronized audio, surface EMG (subcostal/neck), respiratory belt, and optional sternum accelerometer.
• Programming crossover: baseline vs reduced sensitivity (i.e., higher mV value), extended post‑ventricular refractory/blanking, rate‑smoothing ON.
• Positive test: symptoms co‑occur with bursts of non‑physiologic sensed events or noise flags and resolve when sensitivity is relaxed and/or blanking is extended.

What to look for on tracings

• High‑frequency artifact superimposed on EGM without corresponding QRS on surface ECG.
• Runs of very short sensed intervals resulting in pacing inhibition.
• Device logs showing “noise/oversensing episodes,” with transitions into a noise‑handling/asynchronous pacing behavior.
• Fusion/pseudofusion beats (paced spike coincident with intrinsic activation) during irregular respiration or speech.

Programming strategies (stepwise)

Adjustment	Intended effect	Practical notes
Reduce ventricular sensitivity (higher mV)	Make sensing less susceptible to EMG/noise	Balance against need to sense true R‑waves
Extend post‑ventricular blanking/refractory	Ignore short‑coupled artifacts after a beat	Helps with vibration/respiratory artifacts
Enable/tighten rate smoothing	Limit abrupt cycle‑length changes	Reduces symptom perception from timing swings
Adjust lower rate / hysteresis	Reduce competition with intrinsic rhythm	Fewer fusion/pseudofusion beats
Review RR settings	Avoid compounding effects with sensor‑driven rate shifts	Consider higher Activity Threshold or RR OFF during rest

Non‑device mitigations

• Encourage relaxed phonation and diaphragmatic breathing; avoid neck/shoulder isometrics during speech.
• Treat contributory conditions (cough, reflux, bronchospasm) that increase laryngeal/diaphragmatic activity.
• Hydration and posture coaching during prolonged conversations.

Documentation endpoints

• Oversensing/noise burden (events/hour) and percent time in noise‑response mode.
• Symptom–telemetry concordance (time‑locked).
• Change in pauses, fusion/pseudofusion rate, and symptom scores after reprogramming.

Safety: Syncope, prolonged pauses, or injury‑level symptoms warrant urgent evaluation. Always re‑check capture thresholds, impedance, and battery status to exclude end‑of‑service or high‑output programming effects. This content is educational and does not replace clinical judgment.